Extracts vs Synthetic Peptides: Why the Difference Changes What a Purity Figure Means
Half the bioregulator family are extracts and half are synthesised peptides. They are sold alongside each other, discussed interchangeably, and cannot be assessed the same way.
The Difference
A first-generation bioregulator is an extract: a purified peptide fraction taken from animal organ tissue. Thymalin from thymus, Cortexin from brain, Epithalamin from pineal gland, Retinalamin from retina. Each is a mixture of short peptides rather than one defined molecule.
A second-generation bioregulator is a synthesised peptide with a written sequence. Epitalon is Ala-Glu-Asp-Gly. Vilon is Lys-Glu. Livagen is Lys-Glu-Asp-Ala. Each is one exact molecule that can be manufactured to specification.
The difference, in plain language: imagine reproducing a soup someone else made. You could send a jar of the soup itself — it certainly contains whatever made it work, but you cannot say precisely what is in it, and no two batches will be identical. Or you could write down the recipe: four named ingredients, exact quantities, reproducible by anyone, anywhere, forever. The extract is the jar of soup. The synthetic peptide is the recipe.
Why This Changes What a Purity Figure Means
This is the practical consequence, and it matters when assessing any supplier.
For a synthesised peptide, HPLC purity is a real measurement with a clear meaning: of everything detected in the sample, this percentage was the target molecule. There is one target molecule, and the instrument can find it.
For an extract, there is no single target molecule. It is a mixture by definition. So a purity percentage on an extract is not measuring what the same number measures on a synthetic peptide — and a precise-looking figure on an extract should prompt the question of what exactly was measured.
This is not an argument that extracts are inferior. Thymalin and Cortexin carry decades of Russian clinical use, which most synthesised bioregulators cannot claim. It is an argument that they are different kinds of product and need different questions asked of them.
The Pairs Worth Knowing
Several compounds exist in both forms, and the names are close enough to cause genuine confusion.
Epithalamin (extract) and Epitalon (synthetic). Much of the famous animal lifespan work was done with the extract, not the peptide most people now discuss.
Thymalin (extract) and Vilon or Thymogen (synthetics). All three from the same thymic research line.
Cortexin (extract) and Cortagen (synthetic). Both aimed at cortical brain tissue.
Prostatilen (extract) and Prostamax (synthetic). Both prostate.
When you read a claim about any of these, the first question worth asking is which form the study actually used. Evidence does not transfer automatically between them.
Frequently Asked Questions
Compiled by the Southern Pacific Labs research team. Last updated July 2026.
Published References
- Khavinson VK, Malinin VV. “Gerontological Aspects of Genome Peptide Regulation.” Karger AG, Basel, 2005. Source
- Anisimov VN, Khavinson VKh. “Peptide bioregulation of aging: results and prospects.” Biogerontology, 2010. PubMed
- Khavinson VKh. “Peptides and Ageing.” Neuro endocrinology letters, 2002. PubMed
- Fedoreyeva LI, Kireev II, Khavinson VKh, et al. “Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA.” Biochemistry. Biokhimiia, 2011. PubMed
Related Research Guides
More in Foundations
The whole Khavinson system, and where its evidence stands.
Read guide →Pineal Peptide ExtractThe clearest worked example of an extract and its synthetic successor.
Read guide →Thymic Peptide ExtractA first-generation extract with a long Russian clinical record.
Read guide →